Immunotherapy in Multiple Myeloma

To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects. Review of journal articles related to mAbs in MM. The therapeutic options for MM have improved dramatically and the development of mAbs has been associated with...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in oncology nursing 2017-08, Vol.33 (3), p.292-298
Main Authors: Gleason, Charise, Catamero, Donna D.
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - therapeutic use
daratumumab
elotuzumab
Humans
Immunotherapy
monoclonal antibodies
multiple myeloma
Multiple Myeloma - therapy
Nursing
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects. Review of journal articles related to mAbs in MM. The therapeutic options for MM have improved dramatically and the development of mAbs has been associated with improvement in clinical outcomes and favorable toxicity profiles. With appropriate pre-medications and nursing management, mAbs are a well-tolerated treatment option for myeloma patients.
ISSN:0749-2081
1878-3449
DOI:10.1016/j.soncn.2017.05.011